Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Allscripts Healthcare Solutions, Inc is a health information services business based in the US. Allscripts Healthcare Solutions shares (MDRX) are listed on the NASDAQ and all prices are listed in US Dollars. Allscripts Healthcare Solutions employs 8,400 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$5.28 - $17.96|
|50-day moving average||$15.41|
|200-day moving average||$14.25|
|Wall St. target price||$15.27|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$4.40|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Allscripts Healthcare Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Allscripts Healthcare Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Allscripts Healthcare Solutions's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Allscripts Healthcare Solutions shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Allscripts Healthcare Solutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.726. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Allscripts Healthcare Solutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Allscripts Healthcare Solutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2 million.
The EBITDA is a measure of a Allscripts Healthcare Solutions's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.5 billion|
|Gross profit TTM||$684.1 million|
|Return on assets TTM||-1.14%|
|Return on equity TTM||-8.99%|
|Market capitalisation||$2.3 billion|
TTM: trailing 12 months
There are currently 13.4 million Allscripts Healthcare Solutions shares held short by investors – that's known as Allscripts Healthcare Solutions's "short interest". This figure is 14% down from 15.6 million last month.
There are a few different ways that this level of interest in shorting Allscripts Healthcare Solutions shares can be evaluated.
Allscripts Healthcare Solutions's "short interest ratio" (SIR) is the quantity of Allscripts Healthcare Solutions shares currently shorted divided by the average quantity of Allscripts Healthcare Solutions shares traded daily (recently around 2.5 million). Allscripts Healthcare Solutions's SIR currently stands at 5.4. In other words for every 100,000 Allscripts Healthcare Solutions shares traded daily on the market, roughly 5400 shares are currently held short.
However Allscripts Healthcare Solutions's short interest can also be evaluated against the total number of Allscripts Healthcare Solutions shares, or, against the total number of tradable Allscripts Healthcare Solutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Allscripts Healthcare Solutions's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Allscripts Healthcare Solutions shares in existence, roughly 100 shares are currently held short) or 0.1732% of the tradable shares (for every 100,000 tradable Allscripts Healthcare Solutions shares, roughly 173 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Allscripts Healthcare Solutions.
Find out more about how you can short Allscripts Healthcare Solutions stock.
We're not expecting Allscripts Healthcare Solutions to pay a dividend over the next 12 months.
Over the last 12 months, Allscripts Healthcare Solutions's shares have ranged in value from as little as $5.28 up to $17.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allscripts Healthcare Solutions's is 1.0971. This would suggest that Allscripts Healthcare Solutions's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Allscripts Healthcare Solutions, Inc. , together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments: The Core Clinical and Financial Solutions; and The Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for patient engagement, and integrated clinical and financial management solutions, which primarily include EHR-related software; and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Data, Analytics and Care Coordination segment offers practice reimbursement, and payer and life sciences solutions, which are primarily targeted at physician practices, payers, life sciences companies, and other healthcare stakeholders. Its solutions enable clients to transition, analyze, and coordinate care and enhance the healthcare delivery across the care community.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.